[Toxicological study of the choleretic L-H-4,5,6,7-tetrahydro-2-benzyl-L-(morpholino-2-aminoethyl)-4,5-dimethyl-5,7-dioxo-imidazo-4,5-d-pyrimidine (AC 3092)].
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D002118:Calcium / Q000097:blood; D002712:Chlorides / Q000097:blood; D002756:Cholagogues and Choleretics / Q000633:toxicity*; D003864:Depression, Chemical; D004285:Dogs; D004906:Erythrocyte Count; D005260:Female; D006128:Growth / Q000187:drug effects; D006168:Guinea Pigs; D006400:Hematocrit; D006452:Hemoglobinometry; D007958:Leukocyte Count; D008297:Male; D051379:Mice; D009929:Organ Size; D010919:Placebos; D011188:Potassium / Q000097:blood; D011743:Pyrimidines / Q000633:toxicity*; D051381:Rats; D012964:Sodium / Q000097:blood; D013268:Stimulation, Chemical; D014508:Urea / Q000097:blood
D001786:Blood Glucose; D001798:Blood Proteins; D002712:Chlorides; D002756:Cholagogues and Choleretics; D010919:Placebos; D011743:Pyrimidines; D014508:Urea; D012964:Sodium; D011188:Potassium; D002118:Calcium
Etude toxicologique du cholérétique L-H-4,5,6,7-tétrahydro-2-benzyl-l-(morpholino-2-aminoéthyl)-4,6-diméthyl-5,7-dioxo-imidazo-4,5-d-pyrimidine (AC 3092)